BofA Securities Downgrades Ascendis Pharma (ASND) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. COHR
3. CBRS
4. STUB
5. WYFI
6. CRS
7. HLIT
8. ABN:NA
9. ABNRY
10. GLNG

October 20, 2021 6:06 AM EDT
Get Alerts ASND Hot Sheet
Price: $255.46 --0%

Rating Summary:
    21 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 16 | Down: 9 | New: 8
Join SI Premium – FREE

BofA Securities analyst Tazeen Ahmad downgraded Ascendis Pharma (NASDAQ: ASND) from Buy to Neutral with a price target of $169.00 (from $164.00).


For an analyst ratings summary and ratings history on Ascendis Pharma click here. For more ratings news on Ascendis Pharma click here.


Shares of Ascendis Pharma closed at $153.49 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades